Role of Chemokines for the Localization of Leukocyte Subsets in the Kidney

Seminars in Nephrology

Volumn 27, Issue 3, 2007, Pages 260-274

  Segerer, Stephan ^a   Schlöndorff, Detlef ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

B cells; Chemokines; dendritic cells; glomerulonephritis; leukocyte recruitment; macrophages

Indexed keywords

CHEMOKINE;

ARTICLE; B LYMPHOCYTE; CELL COMMUNICATION; CELLULAR DISTRIBUTION; DENDRITIC CELL; HUMAN; LEUKOCYTE; LYMPHOCYTE MIGRATION; MACROPHAGE; MONOCYTE; NEPHRITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; CHEMOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION; KIDNEY; KIDNEY DISEASES; LEUKOCYTES; MACROPHAGES; MODELS, BIOLOGICAL;

EID: 34249083152     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2007.02.003     Document Type: Article

References (126)

1. Strutz F., and Neilson E.G. New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 24 (2003) 459-476
2. Segerer S., and Nelson P.J. Chemokines in renal diseases. ScientificWorld J 5 (2005) 835-844
3. Segerer S., Nelson P.J., and Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11 (2000) 152-176
4. Anders H.J., Ninichuk V., and Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 69 (2006) 29-32
5. Panzer U., Steinmetz O.M., Stahl R.A., and Wolf G. Kidney diseases and chemokines. Curr Drug Targets 7 (2006) 65-80
6. Segerer S., and Alpers C.E. Chemokines and chemokine receptors in renal pathology. Curr Opin Nephrol Hypertens 12 (2003) 243-249
7. Springael J.Y., Urizar E., and Parmentier M. Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev 16 (2005) 611-623
8. Proost P., Struyf S., and Van Damme J. Natural post-translational modifications of chemokines. Biochem Soc Trans 34 (2006) 997-1001
9. Petkovic V., Moghini C., Paoletti S., Uguccioni M., and Gerber B. I-TAC/CXCL11 is a natural antagonist for CCR5. J Leukoc Biol 76 (2004) 701-708
10. Proost P., Struyf S., Couvreur M., Lenaerts J.P., Conings R., Menten P., et al. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP- 2(6-76) as a natural chemokine inhibitor. J Immunol 160 (1998) 4034-4041
11. Murphy P.M., and International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54 (2002) 227-229
12. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., et al., International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
13. Middleton J., Patterson A.M., Gardner L., Schmutz C., and Ashton B.A. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100 (2002) 3853-3860
14. Terricabras E., Benjamim C., and Godessart N. Drug discovery and chemokine receptor antagonists: eppur si muove!. Autoimmun Rev 3 (2004) 550-556
15. El-Asmar L., Springael J.Y., Ballet S., Andrieu E.U., Vassart G., and Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67 (2005) 460-469
16. Springael J.Y., Le Minh P.N., Urizar E., Costagliola S., Vassart G., and Parmentier M. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Mol Pharmacol 69 (2006) 1652-1661
17. Ali S., O'Boyle G., Mellor P., and Kirby J.A. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy. Mol Immunol 44 (2007) 1477-1482
18. Ley K. Arrest chemokines. Microcirculation 10 (2003) 289-295
19. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
20. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 16 (2005) 687-694
21. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22 (2004) 891-928
22. Pruenster M., and Rot A. Throwing light on DARC. Biochem Soc Trans 34 (2006) 1005-1008
23. Wiedermann C.J., Kowald E., Reinisch N., Kaehler C.M., von Luettichau I., Pattison J.M., et al. Monocyte haptotaxis induced by the RANTES chemokine. Curr Biol 3 (1993) 735-739
24. Banas B., Wornle M., Merkle M., Gonzalez-Rubio M., Schmid H., Kretzler M., et al. Binding of the chemokine SLC/CCL21 to its receptor CCR7 increases adhesive properties of human mesangial cells. Kidney Int 66 (2004) 2256-2263
25. Wornle M., Schmid H., Merkle M., and Banas B. Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol 5 (2004) 8
26. Banas B., Wornle M., Berger T., Nelson P.J., Cohen C.D., Kretzler M., et al. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 168 (2002) 4301-4307
27. Weber C., and Koenen R.R. Fine-tuning leukocyte responses: towards a chemokine 'interactome'. Trends Immunol 27 (2006) 268-273
28. Mack M., Luckow B., Nelson P.J., Cihak J., Simmons G., Clapham P.R., et al. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 187 (1998) 1215-1224
29. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 14 (2002) 129-135
30. Forster R., Mattis A.E., Kremmer E., Wolf E., Brem G., and Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87 (1996) 1037-1047
31. Serbina N.V., and Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7 (2006) 311-317
32. Yoshimura T., Matsushima K., Tanaka S., Robinson E.A., Appella E., Oppenheim J.J., et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A 84 (1987) 9233-9237
33. Walz A., Peveri P., Aschauer H., and Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 149 (1987) 755-761
34. Matsushima K., and Oppenheim J.J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1 (1989) 2-13
35. Baggiolini M., Walz A., and Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84 (1989) 1045-1049
36. Gerritsma J.S., van Kooten C., Gerritsen A.F., van Es L.A., and Daha M.R. Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int 53 (1998) 609-616
37. Tang S., Leung J.C., Abe K., Chan K.W., Chan L.Y., Chan T.M., et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111 (2003) 515-527
38. Wada T., Tomosugi N., Naito T., Yokoyama H., Kobayashi K., Harada A., et al. Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 180 (1994) 1135-1140
39. Wada T., Yokoyama H., Tomosugi N., Hisada Y., Ohta S., Naito T., et al. Detection of urinary interleukin-8 in glomerular diseases. Kidney Int 46 (1994) 455-460
40. Segerer S., Henger A., Schmid H., Kretzler M., Draganovici D., Brandt U., et al. Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int 69 (2006) 1765-1773
41. Maus U.A., Waelsch K., Kuziel W.A., Delbeck T., Mack M., Blackwell T.S., et al. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol 170 (2003) 3273-3278
42. Araki M., Fahmy N., Zhou L., Kumon H., Krishnamurthi V., Goldfarb D., et al. Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation 81 (2006) 783-788
43. van Gisbergen K.P., Geijtenbeek T.B., and van Kooyk Y. Close encounters of neutrophils and DCs. Trends Immunol 26 (2005) 626-631
44. Kurts C. Dendritic cells: not just another cell type in the kidney, but a complex immune sentinel network. Kidney Int 70 (2006) 412-414
45. Kluth D.C., Erwig L.P., and Rees A.J. Multiple facets of macrophages in renal injury. Kidney Int 66 (2004) 542-557
46. Sean Eardley K., and Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 68 (2005) 437-455
47. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311 (2006) 83-87
48. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25 (2004) 677-686
49. Martinez F.O., Gordon S., Locati M., and Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177 (2006) 7303-7311
50. Geissmann F., Jung S., and Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
51. Weber C., Weber K.S., Klier C., Gu S., Wank R., Horuk R., et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 97 (2001) 1144-1146
52. Chen S., Bacon K.B., Li L., Garcia G.E., Xia Y., Lo D., et al. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188 (1998) 193-198
53. Feng L., Chen S., Garcia G.E., Xia Y., Siani M.A., Botti P., et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1. Kidney Int 56 (1999) 612-620
54. Lloyd C.M., Dorf M.E., Proudfoot A., Salant D.J., and Gutierrez-Ramos J.C. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol 62 (1997) 676-680
55. Anders H.J., Vielhauer V., Frink M., Linde Y., Cohen C.D., Blattner S.M., et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 109 (2002) 251-259
56. Eis V., Luckow B., Vielhauer V., Siveke J.T., Linde Y., Segerer S., et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 15 (2004) 337-347
57. Tesch G.H., Maifert S., Schwarting A., Rollins B.J., and Kelley V.R. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 190 (1999) 1813-1824
58. Perez de Lema G., Maier H., Nieto E., Vielhauer V., Luckow B., Mampaso F., et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12 (2001) 1369-1382
59. de Lema G.P., Maier H., Franz T.J., Escribese M., Chilla S., Segerer S., et al. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J Am Soc Nephrol 16 (2005) 3592-3601
60. Bird J.E., Giancarli M.R., Kurihara T., Kowala M.C., Valentine M.T., Gitlitz P.H., et al. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice. Kidney Int 57 (2000) 129-136
61. Anders H.J., Frink M., Linde Y., Banas B., Wornle M., Cohen C.D., et al. CC Chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 170 (2003) 5658-5666
62. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
63. Wan H., and Dupasquier M. Dendritic cells in vivo and in vitro. Cell Mol Immunol 2 (2005) 28-35
64. Hume D.A., and Gordon S. Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. J Exp Med 157 (1983) 1704-1709
65. van Kooyk Y., and Geijtenbeek T.B. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3 (2003) 697-709
66. Del Prete A., Locati M., Otero K., Riboldi E., Mantovani A., Vecchi A., et al. Migration of dendritic cells across blood and lymphatic endothelial barriers. Thromb Haemost 95 (2006) 22-28
67. Kruger T., Benke D., Eitner F., Lang A., Wirtz M., Hamilton-Williams E.E., et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 15 (2004) 613-621
68. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
69. Dichmann S., Herouy Y., Purlis D., Rheinen H., Gebicke-Harter P., and Norgauer J. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm Res 50 (2001) 529-533
70. Soos T.J., Sims T.N., Barisoni L., Lin K., Littman D.R., Dustin M.L., et al. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70 (2006) 591-596
71. Kerjaschki D., Regele H.M., Moosberger I., Nagy-Bojarski K., Watschinger B., Soleiman A., et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15 (2004) 603-612
72. Sanchez-Sanchez N., Riol-Blanco L., and Rodriguez-Fernandez J.L. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 176 (2006) 5153-5159
73. Dong X., Swaminathan S., Bachman L., Croatt A., Nath C., and Griffin M. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia/reperfusion injury (2007), Kidney Int In press
74. Angeli V., Ginhoux F., Llodra J., Quemeneur L., Frenette P.S., Skobe M., et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24 (2006) 203-215
75. Martin F., and Chan A.C. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 24 (2006) 467-496
76. Edwards J.C., and Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6 (2006) 394-403
77. Novobrantseva T.I., Majeau G.R., Amatucci A., Kogan S., Brenner I., Casola S., et al. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 115 (2005) 3072-3082
78. Silverman G.J. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms. Arthritis Rheum 54 (2006) 2356-2367
79. Hardtke S., Ohl L., and Forster R. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood 106 (2005) 1924-1931
80. Cyster J.G., Ngo V.N., Ekland E.H., Gunn M.D., Sedgwick J.D., and Ansel K.M. Chemokines and B-cell homing to follicles. Curr Top Microbiol Immunol 246 (1999) 87-93
81. Okada T., and Cyster J.G. B cell migration and interactions in the early phase of antibody responses. Curr Opin Immunol 18 (2006) 278-285
82. Reif K., Ekland E.H., Ohl L., Nakano H., Lipp M., Forster R., et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416 (2002) 94-99
83. Muller G., and Lipp M. Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr Opin Immunol 15 (2003) 217-224
84. Kanemitsu N., Ebisuno Y., Tanaka T., Otani K., Hayasaka H., Kaisho T., et al. CXCL13 is an arrest chemokine for B cells in high endothelial venules. Blood 106 (2005) 2613-2618
85. Ebisuno Y., Tanaka T., Kanemitsu N., Kanda H., Yamaguchi K., Kaisho T., et al. Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J Immunol 171 (2003) 1642-1646
86. Sarwal M., Chua M.S., Kambham N., Hsieh S.C., Satterwhite T., Masek M., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349 (2003) 125-138
87. Steinmetz O.M., Panzer U., Kneissler U., Harendza S., Lipp M., Helmchen U., et al. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 67 (2005) 1616-1621
88. Heller F., Cohen C.D., Lindenmeyer M.T., Brandt U., Draganovici D., Fischereder M., et al. The contribution of B cells to renal interstitial inflammation. Am J Pathol 170 (2007) 457-468
89. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6 (2006) 127-135
90. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 36 (2006) 1357-1366
91. Harrington L.E., Mangan P.R., and Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18 (2006) 349-356
92. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., and Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 (2006) 677-688
93. Ziegler S.F. FOXP3: of mice and men. Annu Rev Immunol 24 (2006) 209-226
94. Colantonio L., Iellem A., Sinigaglia F., and D'Ambrosio D. Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol 32 (2002) 3506-3514
95. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194 (2001) 847-853
96. Zou L., Barnett B., Safah H., Larussa V.F., Evdemon-Hogan M., Mottram P., et al. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 64 (2004) 8451-8455
97. Lim H.W., Broxmeyer H.E., and Kim C.H. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol 177 (2006) 840-851
98. Bystry R.S., Aluvihare V., Welch K.A., Kallikourdis M., and Betz A.G. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2 (2001) 1126-1132
99. Lee I., Wang L., Wells A.D., Dorf M.E., Ozkaynak E., and Hancock W.W. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 201 (2005) 1037-1044
100. Schaniel C., Pardali E., Sallusto F., Speletas M., Ruedl C., Shimizu T., et al. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med 188 (1998) 451-463
101. Mahajan D., Wang Y., Qin X., Wang Y., Zheng G., Wang Y.M., et al. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 17 (2006) 2731-2741
102. Wang Y.M., Zhang G.Y., Wang Y., Hu M., Wu H., Watson D., et al. Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J Am Soc Nephrol 17 (2006) 697-706
103. Muthukumar T., Dadhania D., Ding R., Snopkowski C., Naqvi R., Lee J.B., et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353 (2005) 2342-2351
104. Bucala R., Spiegel L.A., Chesney J., Hogan M., and Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1 (1994) 71-81
105. Quan T.E., Cowper S.E., and Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 8 (2006) 145-150
106. Opalenik S.R., and Davidson J.M. Fibroblast differentiation of bone marrow-derived cells during wound repair. FASEB J 19 (2005) 1561-1563
107. Moore B.B., Kolodsick J.E., Thannickal V.J., Cooke K., Moore T.A., Hogaboam C., et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166 (2005) 675-684
108. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114 (2004) 438-446
109. Abe R., Donnelly S.C., Peng T., Bucala R., and Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166 (2001) 7556-7562
110. Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103 (2006) 14098-14103
111. Ding M., Cui S., Li C., Jothy S., Haase V., Steer B.M., et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 12 (2006) 1081-1087
112. Togel F., Isaac J., Hu Z., Weiss K., and Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67 (2005) 1772-1784
113. Segerer S., Banas B., Wornle M., Schmid H., Cohen C.D., Kretzler M., et al. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 164 (2004) 635-649
114. Segerer S., Mac K.M., Regele H., Kerjaschki D., and Schlondorff D. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 56 (1999) 52-64
115. Segerer S., Cui Y., Hudkins K.L., Goodpaster T., Eitner F., Mack M., et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 11 (2000) 2231-2242
116. Masaki T., Chow F., Nikolic-Paterson D.J., Atkins R.C., and Tesch G.H. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant 18 (2003) 178-181
117. Steinmetz O., Sadaghiani S., Panzer U., Krebs C., Meyer-Schwesinger C., and Streichert T. Antihypertensive therapy induces compartment specific chemokine expression and a Th1 immune response in the clipped kidney of Goldblatt hypertensive rats. Am J Physiol Renal Physiol 292 (2007) F876-F887
118. Panzer U., Steinmetz O.M., Reinking R.R., Meyer T.N., Fehr S., Schneider A., et al. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 17 (2006) 454-464
119. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A 100 (2003) 1885-1890
120. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., and Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361 (1993) 79-82
121. Segerer S., Djafarzadeh R., Gröne H.J., Weingart C., Kerjaschki D., Weber C., et al. Selective binding and presentation of CCL5 by discrete tissue microenvironments during renal inflammation. J Am Soc Nephrol (2007) In press
122. Horuk R., Wang Z.X., Peiper S.C., and Hesselgesser J. Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line. J Biol Chem 269 (1994) 17730-17733
123. Segerer S., Bohmig G.A., Exner M., Colin Y., Cartron J.P., Kerjaschki D., et al. When renal allografts turn darc. Transplantation 75 (2003) 1030-1034
124. Segerer S., Regele H., Mack M., Kain R., Cartron J.P., Colin Y., et al. The duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 58 (2000) 1546-1556
125. Amano H., Bickerstaff A., Orosz C.G., Novick A.C., Toma H., and Fairchild R.L. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts. J Immunol 174 (2005) 6499-6508
126. Pfoertner S., Jeron A., Probst-Kepper M., Guzman C.A., Hansen W., Westendorf A.M., et al. Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol 7 (2006) R54